Bundibugyo Ebola Virus Returns: Why Central Africa’s Outbreak Threatens East Africa

The re-emergence of Bundibugyo ebolavirus disease in Central Africa has been flagged by researchers as an under-recognized but urgent threat to regional health security, one that could rapidly spill across borders into East Africa if surveillance and preparedness systems are not strengthened. In a letter published in New Microbes and New Infections, Yusuf Abdullahi Hubow, Abas Nor Abdi and Nasteho Osman Hassan argue that while Zaire ebolavirus dominates global headlines and drives most vaccine development, Bundibugyo virus has repeatedly caused significant outbreaks with substantial mortality, and its resurgence now coincides with conditions that favor explosive regional spread: porous borders, intense population mobility, busy trade routes, refugee flows, weak surveillance systems and fragile health infrastructure. The authors contend that the deep interconnectedness of Central and East Africa, marked by frequent cross-border movement and shared vulnerabilities, means a localized outbreak could escalate into a regional epidemic before national authorities fully grasp its scope.

Bundibugyo ebolavirus is one of four ebolaviruses known to cause severe disease in humans, alongside Zaire, Sudan and Taï Forest viruses. It was first identified during a 2007 outbreak in Uganda’s Bundibugyo district, and it reappeared in 2012 in the Democratic Republic of Congo. Although its case fatality rate, estimated at approximately 32.8 percent, is lower than the rates associated with Zaire ebolavirus, the letter’s authors emphasize that this figure remains considerable and that BDBV outbreaks have been characterized by delayed detection, rapid spread and significant disruption of health systems. The 2012 outbreak in the Democratic Republic of Congo was particularly instructive from a virological and epidemiological standpoint, because it challenged assumptions about single-source spillover events and revealed complex transmission dynamics that complicate containment efforts. Multiple introductions and chains of human-to-human transmission can blur the epidemiological picture, making contact tracing far more difficult and allowing the virus to persist undetected in communities for critical weeks.

The authors place the current warning in the context of the broader burden that Ebola virus disease continues to exert across the African continent. Recent outbreaks have demonstrated that all four human-pathogenic ebolaviruses can cause severe illness with substantial morbidity and mortality, and that no region with endemic reservoirs can regard itself as permanently safe. Zaire ebolavirus remains the most lethal of the group, but the distinguishing danger of BDBV lies less in its per-case fatality than in the operational conditions under which it emerges: in settings where diagnostic capacity is thin, where early symptoms resemble malaria and other febrile illnesses, and where health systems are already strained, the window for containment narrows dramatically. Delayed recognition allows transmission networks to expand geometrically, and by the time an outbreak is confirmed, the resources required to suppress it multiply.

The catastrophic consequences of delayed action are not hypothetical. The authors point to the West African epidemic of 2013 to 2016, the largest Ebola outbreak in recorded history, which resulted in economic losses exceeding 50 billion dollars, widespread social disruption and a profound erosion of public trust in health institutions. That epidemic demonstrated how a filovirus outbreak in weakly prepared health systems can overwhelm hospitals, orphan entire communities, trigger international travel restrictions and destabilize national economies far beyond the affected districts. It also showed that the costs of preparedness are trivial compared with the costs of response, a lesson that the authors argue has not been fully absorbed in the regions where Bundibugyo virus circulates.

Central and East Africa, the letter argues, remain highly vulnerable because of persistent weaknesses across the entire epidemic-response chain: cross-border surveillance, laboratory confirmation capacity, case detection, contact tracing, infection prevention and control, community trust and emergency response systems. National-level preparedness alone is insufficient for a pathogen with clear regional transmission potential, because the virus does not respect borders and because the populations most exposed to spillover and early transmission are often the least connected to formal health services. The risks of delayed or fragmented action include uncontrolled spread across borders, health system collapse, border closures, economic downturns, the proliferation of misinformation and further loss of community confidence, each of which feeds back into the others and makes the eventual response harder and more expensive.

Conflict-affected areas face additional and compounding barriers. Population displacement disrupts surveillance networks by scattering communities and severing the continuity of health records; insecurity impedes humanitarian access and prevents vaccination teams, contact tracers and laboratory personnel from reaching outbreak epicenters; and fragile governance undermines the coordinated response that epidemic control demands. A systematic review cited by the authors documents the general pattern by which conflict amplifies infectious disease transmission, and eastern regions of the Democratic Republic of Congo, where armed groups operate and displacement camps proliferate, illustrate the problem in acute form. In such environments, an outbreak can burn for months before it is detected, and the standard toolkit of epidemic containment, isolation, tracing and ring vaccination, becomes extraordinarily difficult to deploy.

Against this backdrop, the authors call for Bundibugyo Ebola virus disease to be urgently prioritized by ministries of health, the World Health Organization, Africa CDC, donors, researchers and regional bodies. They note that low-resource border communities, which are often highly mobile or affected by conflict, are especially at risk, and they frame the strengthening of cross-border surveillance not merely as a technical necessity but as a moral imperative of regional solidarity. Real-time information sharing between countries is described as essential for early warning and rapid containment, allowing a case detected in one nation to trigger immediate alert protocols, screening and contact investigation in neighboring territories before the virus can establish new transmission chains.

The letter lays out a detailed agenda for joint outbreak preparedness between Central and East African nations, built on harmonized protocols covering detection, isolation, referral, infection prevention and control measures, contact tracing, risk communication, community engagement, logistics support, genomic surveillance and emergency financing mechanisms. Specific recommendations include expanding rapid diagnostic testing networks with mobile laboratories capable of deployment at outbreak epicenters, training frontline health workers in Ebola recognition and safe patient management, investing in sustainable emergency response teams, and enhancing genomic surveillance for real-time tracking of viral evolution. Genomic sequencing, the authors suggest, would allow epidemiologists to distinguish between new spillover events and continuing human-to-human transmission, a distinction with direct operational consequences for how an outbreak is contained.

Notably, the authors highlight a critical gap in the countermeasure arsenal: no licensed vaccine currently exists for Bundibugyo ebolavirus. The most advanced Ebola vaccines, including the rVSV-ZEBOV vaccine deployed successfully against Zaire ebolavirus outbreaks, are designed to target that specific species, and their cross-protection against BDBV is uncertain. The authors therefore call for vaccine and therapeutic research tailored specifically to BDBV, arguing that the current imbalance in the research pipeline reflects publicity rather than risk. They further recommend improved coordination among ministries of health, the WHO, Africa CDC, the East African Community and humanitarian agencies, alongside risk communication strategies that build community trust while actively countering misinformation, and the institutionalization of joint simulation exercises at border crossings to test operational readiness under realistic conditions.

The letter closes with a direct appeal: the re-emergence of Bundibugyo Ebola virus disease is a clarion call for urgent regional action, and without decisive investment in cross-border surveillance and epidemic preparedness grounded in evidence-based policy and multisectoral collaboration, localized outbreaks will continue to threaten the health security of the entire region. Equitable resource allocation for fragile border populations is singled out as a priority, since these communities bear the highest exposure risk with the fewest protective services. The authors’ message is ultimately one of timing: governments and international partners now have the opportunity to act collectively, before another preventable crisis unfolds, and the experience of past Ebola epidemics demonstrates both the price of inaction and the feasibility of prevention when surveillance, laboratory capacity and community engagement are funded and coordinated across borders.

Subject of Research: Re-emergence of Bundibugyo ebolavirus disease in Central Africa and the need for cross-border surveillance and epidemic preparedness in East Africa

Article Title: Re-emergence of Bundibugyo Ebola virus disease in Central Africa: A critical threat to regional health security and the imperative for cross-border surveillance and epidemic preparedness in East Africa

Article References: Hubow, Y. A., Abdi, A. N., & Hassan, N. O. (2026). Re-emergence of Bundibugyo Ebola virus disease in Central Africa: A critical threat to regional health security and the imperative for cross-border surveillance and epidemic preparedness in East Africa. New Microbes and New Infections, 74, Article 101852. https://doi.org/10.1016/j.nmni.2026.101852

Image Credits: AI Generated

DOI: 10.1016/j.nmni.2026.101852

Keywords: Bundibugyo ebolavirus, Ebola virus disease, Central Africa, East Africa, cross-border surveillance, epidemic preparedness, outbreak response, genomic surveillance, vaccine research, health security, infection prevention and control, conflict and disease